Literature DB >> 22013226

Neither proteinuria nor albuminuria is associated with endothelial dysfunction in HIV-infected patients without diabetes or hypertension.

Samir K Gupta1, Changyu Shen, Kieren J Mather, Rajiv Agarwal, Michael P Dubé.   

Abstract

It is unknown whether systemic endothelial dysfunction underlies the association between nephropathy and cardiovascular disease (CVD) in persons infected with human immunodeficiency virus (HIV). Spot urine protein to creatinine ratio, spot urine albumin to creatinine ratio, creatinine clearance, estimated glomerular filtration rate, and flow-mediated dilation (FMD) of the brachial artery were evaluated in 123 study participants infected with HIV (58 receiving antiretroviral therapy [ART] and 65 not receiving ART) with no history of diabetes or hypertension. None of the renal markers, modeled as either continuous or categorical variables, correlated with FMD. Contrary to expectations, endothelial dysfunction may not be the link between nephropathy and CVD in HIV.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22013226      PMCID: PMC3209818          DOI: 10.1093/infdis/jir668

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force.

Authors:  Mary C Corretti; Todd J Anderson; Emelia J Benjamin; David Celermajer; Francois Charbonneau; Mark A Creager; John Deanfield; Helmut Drexler; Marie Gerhard-Herman; David Herrington; Patrick Vallance; Joseph Vita; Robert Vogel
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

2.  Impaired vascular reactivity in African-American patients with type 2 diabetes mellitus and microalbuminuria or proteinuria despite angiotensin-converting enzyme inhibitor therapy.

Authors:  A Jawa; S Nachimuthu; M Pendergrass; S Asnani; V Fonseca
Journal:  J Clin Endocrinol Metab       Date:  2005-10-11       Impact factor: 5.958

3.  Proteinuria and endothelial dysfunction in stable HIV-infected patients. A pilot study.

Authors:  Samir K Gupta; Kieren J Mather; Rajiv Agarwal; Chandan K Saha; Robert V Considine; Michael P Dubé
Journal:  J Acquir Immune Defic Syndr       Date:  2007-08-15       Impact factor: 3.731

4.  Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects.

Authors:  Samir K Gupta; Lauren Komarow; Roy M Gulick; Richard B Pollard; Gregory K Robbins; Nora Franceschini; Lynda A Szczech; Susan L Koletar; Robert C Kalayjian
Journal:  J Infect Dis       Date:  2009-08-15       Impact factor: 5.226

5.  Endothelial function in HIV-infected persons.

Authors:  Anthony Solages; Joseph A Vita; David J Thornton; Jessica Murray; Timothy Heeren; Donald E Craven; C Robert Horsburgh
Journal:  Clin Infect Dis       Date:  2006-03-31       Impact factor: 9.079

6.  Microalbuminuria in HIV infection.

Authors:  Lynda Anne Szczech; Carl Grunfeld; Rebecca Scherzer; Jesse A Canchola; Charles van der Horst; Stephen Sidney; David Wohl; Michael G Shlipak
Journal:  AIDS       Date:  2007-05-11       Impact factor: 4.177

7.  The effects of HIV type-1 viral suppression and non-viral factors on quantitative proteinuria in the highly active antiretroviral therapy era.

Authors:  Samir K Gupta; Marlene Smurzynski; Nora Franceschini; Ronald J Bosch; Lynda A Szczech; Robert C Kalayjian
Journal:  Antivir Ther       Date:  2009

8.  Relations of measures of endothelial function and kidney disease: the Framingham Heart Study.

Authors:  Meredith C Foster; Michelle J Keyes; Martin G Larson; Joseph A Vita; Gary F Mitchell; James B Meigs; Ramachandran S Vasan; Emelia J Benjamin; Caroline S Fox
Journal:  Am J Kidney Dis       Date:  2008-07-09       Impact factor: 8.860

9.  CD4+ count-guided interruption of antiretroviral treatment.

Authors:  W M El-Sadr; J D Lundgren; J D Neaton; F Gordin; D Abrams; R C Arduino; A Babiker; W Burman; N Clumeck; C J Cohen; D Cohn; D Cooper; J Darbyshire; S Emery; G Fätkenheuer; B Gazzard; B Grund; J Hoy; K Klingman; M Losso; N Markowitz; J Neuhaus; A Phillips; C Rappoport
Journal:  N Engl J Med       Date:  2006-11-30       Impact factor: 91.245

10.  T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women.

Authors:  Robert C Kaplan; Elizabeth Sinclair; Alan L Landay; Nell Lurain; A Richey Sharrett; Stephen J Gange; Xiaonan Xue; Peter Hunt; Roksana Karim; David M Kern; Howard N Hodis; Steven G Deeks
Journal:  J Infect Dis       Date:  2011-01-10       Impact factor: 5.226

View more
  5 in total

1.  Relationships between renal parameters and serum and urine markers of inflammation in those with and without HIV infection.

Authors:  Takashi Shinha; Deming Mi; Ziyue Liu; Christie M Orschell; Michael M Lederman; Samir K Gupta
Journal:  AIDS Res Hum Retroviruses       Date:  2015-02-26       Impact factor: 2.205

Review 2.  Hypertension in HIV-Infected Adults: Novel Pathophysiologic Mechanisms.

Authors:  Sasha A Fahme; Gerald S Bloomfield; Robert Peck
Journal:  Hypertension       Date:  2018-05-18       Impact factor: 10.190

3.  Markers of renal disease and function are associated with systemic inflammation in HIV infection.

Authors:  S K Gupta; D Kitch; C Tierney; K Melbourne; B Ha; G A McComsey
Journal:  HIV Med       Date:  2015-05-20       Impact factor: 3.180

4.  Microvascular endothelial dysfunction is associated with albuminuria and CKD in older adults.

Authors:  Stephen L Seliger; Shabnam Salimi; Valerie Pierre; Jamie Giffuni; Leslie Katzel; Afshin Parsa
Journal:  BMC Nephrol       Date:  2016-07-13       Impact factor: 2.388

5.  Urinary albumin-to-creatinine ratio is associated with endothelial dysfunction in HIV-infected patients receiving antiretroviral therapy.

Authors:  Matteo Pirro; Massimo R Mannarino; Daniela Francisci; Elisabetta Schiaroli; Vanessa Bianconi; Francesco Bagaglia; Amirhossein Sahebkar; Elmo Mannarino; Franco Baldelli
Journal:  Sci Rep       Date:  2016-06-29       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.